DOCS
Doximity Inc

4,059
Mkt Cap
$4.53B
Volume
1,035.00
52W High
$76.51
52W Low
$23.53
PE Ratio
20.60
DOCS Fundamentals
Price
$24.53
Prev Close
$25.10
Open
$24.30
50D MA
$36.77
Beta
1.31
Avg. Volume
2.68M
EPS (Annual)
$1.11
P/B
4.63
Rev/Employee
$687,227.71
$10,772.83
Loading...
Loading...
News
all
press releases
William Blair Investment Management LLC Acquires 609,775 Shares of Doximity, Inc. $DOCS
William Blair Investment Management LLC raised its holdings in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 11.7% during the third quarter, according to its most recent filing with the Securities...
MarketBeat·21h ago
News Placeholder
More News
News Placeholder
Doximity, Inc. (NYSE:DOCS) Receives Consensus Rating of "Moderate Buy" from Analysts
Doximity, Inc. (NYSE:DOCS - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine brokerages that are covering the company, MarketBeat reports. Three analysts have...
MarketBeat·1d ago
News Placeholder
Andra AP fonden Makes New Investment in Doximity, Inc. $DOCS
Andra AP fonden purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission...
MarketBeat·1d ago
News Placeholder
Doximity, Inc. (NASDAQ:DOCS) Receives Consensus Rating of "Moderate Buy" from Brokerages
Doximity, Inc. (NASDAQ:DOCS - Get Free Report) has been given an average rating of "Moderate Buy" by the twenty brokerages that are covering the stock, MarketBeat Ratings reports. Five investment...
MarketBeat·5d ago
News Placeholder
Doximity (NASDAQ:DOCS) Sets New 12-Month Low on Analyst Downgrade
Doximity (NASDAQ:DOCS) Sets New 1-Year Low Following Analyst Downgrade...
MarketBeat·7d ago
News Placeholder
Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at JPMorgan Chase & Co.
JPMorgan Chase & Co. decreased their price objective on Doximity from $40.00 to $33.00 and set a "neutral" rating on the stock in a report on Friday...
MarketBeat·10d ago
News Placeholder
Teladoc Q4 Earnings: Can Integrated Care Strength Save Profits?
TDOC heads into Q4 earnings with an improving loss outlook and rising Integrated Care EBITDA, but BetterHelp declines may weigh on revenues.
Zacks·11d ago
News Placeholder
PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up
PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.
Zacks·17d ago
News Placeholder
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?
In preliminary, unaudited financial results, TEM posts 83% revenue growth and record data sales in 2025, but valuation and ongoing GAAP losses cloud the outlook before Q4 earnings.
Zacks·17d ago
News Placeholder
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
Avantor stock sinks 13% as Q4 earnings beat estimates, but revenues slip, margins contract and 2026 outlook signals more pressure ahead.
Zacks·18d ago
<
1
2
...
>

Latest DOCS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.